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Background: For women facing gonadotoxic treatment, cryopreservation of ovarian tissue with subsequent
retransplantation during remission is a promising technique for fertility preservation. However, follicle loss within
grafted ovarian tissue can be caused by ischemia and progressive revascularization. Several xenograft models using
different immunodeficient rodent lines are suitable for studying ovarian tissue survival and follicular viability after
frozen-thawed ovarian cortex transplantation. SCID mice, which are deficient for functional B and T cells, are the
most commonly used mice for ovarian xenograft studies. However, due to incomplete immunosuppression, NOD-SCID
mice displaying low NK cell function and an absence of circulating complement might be more appropriate. The
present study aims to define the most appropriate immunodeficient mouse strain for ovarian tissue xenotransplantation
by comparing ovarian graft recovery in SCID and NOD-SCID mice following engraftment in the presence of isoform
111 of vascular endothelial growth factor.
Methods: Sheep ovarian cortex fragments were embedded in a collagen matrix, with or without VEGF111, before
being stitched onto the ovaries of SCID and NOD-SCID mice. Transplants were recovered after 3 days to study early
revascularization or after 3 weeks to evaluate follicle preservation and tissue fibrosis through histological analyses.
Results: At day 3, vessels were largely reorganized in the ovarian grafts of both mouse strains. After 3 weeks, the
cortical tissue was clearly identifiable in SCID mice but not in NOD-SCID mice. Upon VEGF111 treatment, vascularization
was significantly improved 3 days after transplantation in SCID mice. This increase in vessel density was correlated with
better follicular preservation in SCID mice 3 weeks after transplantation. Fibrosis was not decreased by VEGF treatment
in either mouse strain.
Conclusions: Tissue architecture and follicular morphology were better preserved in ovarian tissues grafted in SCID
mice in comparison with NOD-SCID mice. Moreover, tissue revascularization was improved in SCID mice by VEGF111
graft treatment. Thus, we consider SCID mice to be the best murine model for studying ovarian tissue xenografts.Background
To date, the future fertility of women with cancer remains
a major concern because these women often face ovarian
damage and premature ovarian failure after gonadotoxic
treatments. For patients who need immediate chemother-
apy or for prepubertal girls, ovarian cortex cryopreserva-
tion represents a promising fertility preservation technique
[1]. Thus far, autologous transplantation of frozen/thawed
ovarian tissue has allowed for the birth of more than 30
babies worldwide [2].* Correspondence: c.munaut@ulg.ac.be
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unless otherwise stated.For autologous transplantation of frozen/thawed ovarian
tissue, graft neovascularization remains a limiting factor
for survival. Indeed, the lack of vascular anastomosis after
tissue transplantation is responsible for early transplant is-
chemia, which decreases the ovarian tissue survival rate
and gives rise to massive follicular loss by apoptosis [3-7].
To study ovarian tissue survival and follicular viability
after frozen-thawed ovarian cortex transplantation, several
xenograft models using different immunodeficient rodent
lines have been developed and published. Indeed, in vivo
research using preclinical models represent a crucial step
before clinical application. Severe combined immunodefi-
cient (SCID) mice were the first and most commonly used
mice for ovarian xenografts [5,8,9]. This mouse strain isal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Fransolet et al. Journal of Ovarian Research  (2015) 8:14 Page 2 of 8characterized by the scid mutation, which leads to a defect
in the recombination of antigen receptor genes, impairing
the capacity to generate functional B and T lymphocytes
[10,11]. This deficiency contributes to the acceptance of
xenogeneic grafts without severe rejection. However, in 2
to 25% of young adult mice, the mutation is not com-
pletely stable [12]. In this context, development and mat-
uration of lymphocytes can occur and lead to incomplete
immunosuppression, which may limit the grafting effi-
ciency of xenogeneic tissues [13]. Therefore, long term
foreign tissue rejection represents an important issue in
SCID mice. A few years after SCID mice generation, the
scid mutation was transferred into a Non-Obese Diabetic
(NOD) background. This transfer leads to NOD-SCID
mice, which have reduced NK cell activity in addition to
the deficiency in functional B and T cells [14]. Moreover,
their ability to activate some components of the comple-
ment system is impaired, and these mice are markedly
deficient in macrophages [15]. Based on these multiple
defects in innate and adaptive immunity, the NOD-SCID
strain is expected to be more promising as a tool for
xenotransplantation.
To reduce the hypoxic period after tissue transplant-
ation and improve follicular preservation, angiogenesis
can be stimulated by vascular endothelial growth factor,
which is the main signaling protein that regulates new
vessel formation from pre-existing vessels. The effects of
two VEGF-A isoforms, VEGF111 and VEGF165, were re-
cently tested in a xenograft model developed in our lab
using SCID mice [16,17]. These VEGF isoforms were
chosen for their unique properties; VEGF111 is soluble and
resistant to proteolysis, whereas VEGF165 is addition-
ally anchored to the extracellular matrix. Both VEGF
isoforms increase blood vessel recruitment and func-
tional angiogenesis.
Due to differences in immune response, the mouse
strain used in the xenograft model can significantly im-
pact the results. The aim of the present study was to de-
termine the most appropriate experimental model, SCID
or NOD-SCID mice, for ovarian cortex transplantation.
Histological and functional features of frozen-thawed
sheep ovarian cortex with or without VEGF111 treatment
were subsequently analyzed.
Methods
Collection and preparation of ovarian tissue
Ovarian cortex from sheep was obtained and prepared
as described previously [16]. The Animal Ethics Com-
mittee of the University of Liège approved the use of
sheep ovarian tissue obtained from the Ovine Research
Center (University of Namur). Briefly, after euthanasia,
ovaries were transferred and kept at 4°C until processing
in Leibovitz L-15 medium (Lonza, Verviers, Belgium,
BE12-700 F) supplemented with 10% normal sheepserum (Hormonology Laboratory, Marloie, Belgium). In
the laboratory, the medulla was removed and the cortex
was cut into strips (5 × 5 × 1 mm) before equilibration
during 30 min at 4°C in cryopreservative medium con-
taining Leibovitz L-15 medium supplemented with 10%
normal sheep serum, 10% dimethylsulfoxide (1.5 M)
(Sigma-Aldrich, Bornem, Belgium) and 0.1 M sucrose.
Freezing and thawing of ovarian tissue
Ovarian biopsies were cooled in a programmable freezer
(CL-8800i system, CryoLogic, Mulgrave, Victoria, Australia)
in cryovial tubes (Simport, Montreal, Quebec, Canada) as
described previously [18] and stored in liquid nitrogen until
transplantation. At transplantation, the cryovials were incu-
bated at room temperature for 2 min and thawed by rapid
immersion at 37°C in a water bath. To remove the cryopro-
tectant, cortical fragments were washed three times for
5 min at 37°C in serum-free Leibovitz medium.
Ovarian transplant encapsulation
Cortical biopsies of 2.5 × 2.5 × 1 mm from 20 ewes were
embedded in a three-dimensional collagen matrix as
previously described [16]. On a heating plate, a first layer
of type I collagen extracted from the tail tendons of rats
[19] was poured in an agar ring. The collagen matrix
was prepared by mixing 9 volumes of type I collagen
(2.4 mg/ml), 1 volume of 10× minimal essential medium
and approximately 0.1 volume of 1 M NaOH to adjust
the pH to 7.4. After polymerization, frozen-thawed ovar-
ian strips pierced with surgical thread were placed and
overlaid by a second layer of type I collagen.
VEGF111 was produced and purified as previously de-
scribed [16,20] and then included in the collagen of
treated group at a concentration of 100 nM.
Mouse transplantation and sacrifice
Eight-week-old severe combined immunodeficient (SCID,
n = 32) or non-obese diabetic SCID (NOD-SCID, n = 19)
mice (Charles River, Saint-Germain-sur-l’Arbresle, France)
were anesthetized with an intraperitoneal injection of
ketamine (100 mg/kg) and xylazine (10 mg/kg). An encap-
sulated ovarian biopsy was stitched onto the ovary with a
7–0 Prolene suture. Fragments from 2 different ewes were
usually used per experiment.
To study the functional vascular network, 200 μl of dex-
tran/fluorescein isothiocyanate (FITC) (2.5 mg/ml in PBS)
(Sigma-Aldrich, Belgium) was intravenously injected 3 min
before sacrifice. Animals were euthanized by cervical dis-
location 3 days or 3 weeks after grafting. The sheep ovarian
transplants were recovered and fixed in 4% formaldehyde.
Histological assessment
Each graft was cut into 5-μm-thick serial sections. Ten
sections per transplant, which covered the entire ovarian
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(H&E).
To detect the functional vascular network, immunostain-
ing was performed in one step. Sections were deparaffi-
nized and rehydrated, and endogenous peroxidase activity
was blocked by incubating the sections in 3% hydrogen
peroxide for 20 min at room temperature (RT). Non-
specific binding sites were blocked by incubation with
phosphate-buffered saline (PBS) containing 10% bovine
serum albumin for 30 min at RT. The sections were incu-
bated with a ready-to-use anti-fluorescein antibody
(Converter-POD, Roche, France), which directly recog-
nized the FITC molecules fixed on dextran, for 30 min at
RT. Negative control slides were also performed by re-
placing the antibody with phosphate-buffered saline
(PBS). The 3,3′-diaminobenzidine substrate (K3468, Dako,
Belgium) allowed the visualization of positively stained cells,
and the sections were counterstained with haematoxylin.
Fibrosis was evaluated using saffron staining. Sections
were incubated in 1% saffron solution (Microm Microtech,
Francheville, France) in 100% ethanol for 10 min at 37°C.Virtual image acquisition
Slides were digitized in brightfield at 20× magnification
using the NanoZoomer 2.0-HT C9600-13 (Hamamatsu
Photonics, K.K., Japan), a high-speed and high-resolution
digital slide scanner system. Digital images were acquired
in .ndpi format and visualized with NDP.view software
(Olympus) on a standard PC.Histological analysis of follicle numbers
At least 10 H&E sections per fragment were analyzed by
Image J software in order to limit the impact of natural
follicular heterogeneity on experimental results [21]. Fol-
licles were quantified manually and, to avoid double
counting, only follicles with a visible nucleus were taken
into account. Follicles were then classified according to
their maturity (primordial, primary or secondary folli-
cles). Follicular densities (number/mm2) were calculated
after a manual surrounding of the cortical surface (Image
J software).Vascular network analysis
Stained vessels were drawn manually on digital images
and transformed to obtain a binarized image in which
the intensity of pixels representing vessels was set to 1
and that corresponding to the background was set to 0.
The number of vessel sections was measured automatically
on the binary images [22,23]. The results are expressed as
unity of area of ovarian tissue. An image analysis was con-
ducted using MATLAB 8.1.0.604 (R2013a) software
(Mathworks, Inc.).Fibrosis analysis
Digital images of saffron-stained tissue slices were ana-
lyzed using ImageJ software (National Institutes of Health,
USA). Digitized color images were first decomposed into
their red, green, and blue components. To enhance the
features of fibrosis, the blue component was subtracted
from the red component. The resulting images were then
binarized using an appropriate threshold. In this method,
pixels that were associated with fibrosis were assigned a
value of 1, and pixels that were associated with non-
fibrotic tissue were assigned a value of 0. The ratio of the
surface area that was occupied by fibrotic tissue to the
total surface area of the tissue represented the proportion
of fibrotic tissue in each transplant.
Statistical analysis
Statistical analyses were performed using GraphPad
Prism software (GraphPad, San Diego, CA). The Mann–
Whitney test was applied for comparisons between two
different groups. The proportion of positive fragments
for dextran/FITC-stained blood vessels was compared
with a chi-square test. A probability of p < 0.05 was con-
sidered to be statistically significant.
Results
Graft recovery and histological examination
Mice were sacrificed 3 days or 3 weeks after transplant-
ation, and all 102 ovarian xenografts were recovered from
the SCID (n = 32) and NOD-SCID (n = 19) mice. For tech-
nical reasons, two transplants could not be analyzed. The
cortex and medulla were clearly detectable on fresh ovar-
ian tissue. Most of the follicles were located in the cortex,
whereas the medulla contained a highly vascular stroma
(Figure 1A). After grafting, haematoxylin and eosin stain-
ing of tissue sections revealed major remodeling of the
preexisting vessels compared to fresh tissue as soon
as 3 days after transplantation in both mouse strains
(Figure 1B, C). Nevertheless, at day 3 post transplant-
ation, the tissue architecture, cortex and medulla were
still recognizable. In sharp contrast, grafts recovered
after 3 weeks of transplantation displayed extensive tissue
remodeling in both mouse strains (Figure 1D, E). The
overall tissue histology displayed better morphology in
SCID compared to NOD-SCID mice. The cortex of the bi-
opsy transplanted in SCID mice was easily identified,
while the tissue grafted in NOD-SCID mice appeared
more disorganized.
No effect of VEGF111 on ovarian tissue fragment histology
was observed at 3 days or 3 weeks post transplantation.
Graft neovascularization
Dextran/FITC injections were performed before sacri-
fice, and perfused transplants were evaluated at day 3
post transplantation by immunohistochemical detection
AB C
D E
Figure 1 Histological analysis of haematoxylin and eosin sections of ovarian tissue. Representative illustrations of fresh ovarian tissue
before cryopreservation (the cortex and medulla are identified by a plain and dotted arrow, respectively) (A); ovarian control grafts 3 days after
transplantation in SCID mice (B) and NOD-SCID mice (C); ovarian control grafts 3 weeks after transplantation in SCID mice (D) and NOD-SCID
mice (E). ► Indicates vessels. Scale bar: 500 μM. Images are representative of at least 2 experiments.
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the percentage of perfused transplants only in SCID
mice (Table 1). Functional blood vessel density was also
higher in fragments grafted in SCID mice following
treatment with VEGF111 (Figure 3).
Follicular morphology and density
Morphologically, follicles from tissue grafted for 3 weeks
in both mouse strains were indistinguishable from those
from fresh tissue (Figure 4A). Follicles from SCID mouse
transplanted tissue were round and contained fewer vac-
uoles (Figure 4B). In NOD-SCID mice, despite a well-
organized granulosa cell layer and intact oocytes, folli-
cles displayed ooplasm with many vacuoles (Figure 4C).
To determine if ovarian cortex treatment with VEGF111
could improve follicular survival, follicular density was
evaluated in SCID and NOD-SCID mice (Figure 4D, E).
Compared to vehicle treated controls, VEGF111 had an im-
pact on primordial follicle preservation in SCID mice.Fibrosis analysis
To further the tissue remodeling analysis, fibrosis was
evaluated by saffron staining. Analysis of fresh and frozen-
thawed tissues compared to tissue grafted over 3 weeks
showed that fibrosis was significantly increased after trans-
plantation. Among grafted ovarian tissues, fibrotic areas
were found to be similar in controls and in VEGF-treated
groups, regardless of the mouse strain (Figure 5).
Discussion
Fertility restoration after transplantation of frozen-thawed
ovarian tissue is a major concern in reproductive medi-
cine. To improve the process, many xenograft models
have been used [5]. Indeed, establishing rapid perfusion of
the transplant associated with a significant follicular pres-
ervation in a mouse model could be very useful in the
clinic for human ovarian tissue autotransplantation. This
study was undertaken to compare results obtained after
ovarian tissue xenotransplantation in two different
15 CT
BA
Figure 2 Functional vascular network identification in ovarian tissue 3 days after transplantation in SCID and NOD-SCID mice.
Representative illustrations of functional blood vessels (identified by plain arrows) revealed by dextran-FITC immunostaining in VEGF111 treated
fragments grafted in SCID (A) and NOD-SCID (B) mice. Scale bar: 500 μM. Images are representative of at least 2 experiments.
Fransolet et al. Journal of Ovarian Research  (2015) 8:14 Page 5 of 8immunodeficient mice strains. Using a pre-clinical mouse
model, we provide evidence that the morphological fea-
tures of transplanted ovarian tissue could be impacted by
the mouse strain. Our results indicate that graft perfusion
and follicular preservation were better in ovarian frag-
ments grafted in SCID mice.
The period before revascularization of frozen-thawed
ovarian tissue grafts appears to be the main factor re-
sponsible for the ischemic damage that decreases the
lifespan of the transplant [3,24]. The electron paramag-
netic resonance oximetry technique highlighted the ob-
servation that progressive revascularization of the tissue
starts 5 days after grafting [25]. Therefore, several xeno-
graft studies have been performed to restore earlier blood
supply in an attempt to improve follicular preservation by
limiting ischemic damage. Surprisingly, although angio-
genesis was successively promoted, better vascularization
was not always associated with follicular preservation
improvement [16,17,26-29]. In line with these previous
publications, our results confirm the angiogenic effect of
VEGF111. However, the impact on primordial follicular
preservation was observed only in SCID mice whose xe-
nografts were treated with VEGF111. Primary follicles were
better preserved in NOD-SCID than in SCID mice. How-
ever, the low density of primary follicles observed in the
biopsies after 3 weeks of transplantation suggests that theTable 1 Percentage of ovarian transplants positive for
dextran/FITC staining 3 days after transplantation in
SCID and NOD-SCID mice
n (%) n (%)
SCID Negative Positive
CT (n = 21) 13 (62) 8 (38)
VEGF111 (n = 19) 8 (42) 11 (58)
NOD-SCID Negative Positive
CT (n = 8) 2 (25) 6 (75)
VEGF111 (n = 6) 3 (50) 3 (50)biological significance of these results is questionable.
Moreover, heterogeneous follicular distribution within
sheep ovarian cortex may have an impact on the results
[21]. Follicle preservation or functional vascular network
and fibrotic surface analyses did not reveal any significant
differences between the two mouse strains; however, as
previously described, we confirmed that ovarian tissue
transplantation itself induces fibrosis [6]. Histological ana-
lysis indicates that ovarian tissue transplantation in SCID
mice better preserves global tissue architecture and fol-
licular morphology in comparison to tissue grafted in
NOD-SCID mice. Other studies have also reported that
damage to stromal cells as well as follicular alterations
occur during the first days after transplantation [6,7]. Im-
munodeficient mice constitute a valuable tool for studying
xenografts and tumorigenesis. Since 1960, athymic mice
(nude) have been the standard for establishing in vivo
models of human malignancies. An attractive alternative
to this model is SCID mice, which lack functional T and B
cells but retain normal natural killer (NK) cell activity.
NOD-SCID mice have additional immunologic defects,






























Figure 3 Functional vascular network analysis of ovarian tissue
3 days after transplantation in SCID and NOD-SCID mice.
Quantification of functional vessel density in ovarian transplants with or










































































Figure 4 Follicle analysis of ovarian tissue 3 weeks after transplantation in SCID and NOD-SCID mice. H&E sections of fresh ovarian tissue
(A) and ovarian control tissue transplanted in SCID (B) and NOD-SCID (C) mice (primordial and primary follicles are identified by plain and dotted
arrows, respectively). Quantification of primordial (D) and primary (E) follicle density in ovarian transplants with or without VEGF111 treatment and
grafted in SCID or NOD-SCID mice. Scale bar: 100 μM. Images are representative of at least 2 experiments.
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erature regarding the type of immunodeficient mice to use
for frozen-thawed ovarian tissue xenotransplantation.
Recently, different grafting sites were evaluated in nude
mice; all transplantation sites equally supported follicular
growth and preserved quiescent follicles and stromal
fibrosis [30].
In the context of ovarian tissue recovery after auto-
transplantation, immunity may play an important role
that is overlooked in studies using immunodeficient
mice for xenografts. Indeed, to be more representative
of the clinical process, the use of humanized animal
models could be interesting [31]. In fact, to observe the
“pure” human immune response, the recipient mice should












Figure 5 Fibrosis analysis of ovarian tissue 3 weeks after transplantat
fresh and frozen-thawed (F-T) ovarian biopsies and ovarian transplants graf(MHC) genes or express certain human leukocyte an-
tigens (HLA).
Conclusions
To our knowledge, this is the first study undertaken to test
and compare two different immunodeficient mouse strains
with a BALB/c background (SCID and NOD-SCID) as
hosts and to assess the benefit of grafts treated with
VEGF111. Our results indicate that sheep ovarian tissue xe-
nografts in SCID and NOD-SCID mice are both suitable
for studying graft recovery. However, based on histologic
analysis, the overall tissue morphology is better preserved
in SCID mice. Moreover, in this mouse strain, grafted ovar-
ian tissues treated with VEGF isoform 111 display better





ion in SCID and NOD-SCID mice. Percentage of fibrotic tissue in
ted in SCID and NOD-SCID mice. ***p < 0.001.
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